Ketalar Injection
Product Images NDC 42023-115

4 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ketalar (NDC 42023-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketalar Chemial Structure (Ketalar 1)

Ketalar Chemial Structure (Ketalar 1)
Chemical structure of ketamine hydrochloride, the active ingredient in Ketalar injection. The diagram depicts the molecular arrangement including a cyclohexanone ring, a chlorophenyl group, and an amine functional group as part of the ketamine molecule, combined with hydrochloride.*
FDA Label Image

20 mL Multiple Dose Vial (Ketalar 2)

20 mL Multiple Dose Vial (Ketalar 2)
Ketalar 200 mg/20 mL (10 mg/mL) injection label for slow intravenous or intramuscular use, supplied in a 20 mL multiple-dose vial. The label includes active ingredient concentration, usage instructions, storage conditions, NDC 42023-113-10, lot and expiration date fields, and distributor information for Par Health USA, LLC in Chestnut Ridge, NY.*
FDA Label Image

10 mL Multiple Dose Vial (Ketalar 3)

10 mL Multiple Dose Vial (Ketalar 3)
Ketalar 500 mg/10 mL (50 mg/mL) injection label for ketamine hydrochloride by Par Health USA, LLC. The label indicates it is for slow intravenous or intramuscular use and describes a 10 mL multiple-dose vial. It includes dosage and storage information along with lot and expiration date boxes.*
FDA Label Image

5 mL Multiple Dose Vial (Ketalar 4)

5 mL Multiple Dose Vial (Ketalar 4)
Ketalar 100 mg/mL (500 mg/5 mL) injection concentrate label for slow intravenous or intramuscular use. The label states the product must be diluted prior to use and is a 5 mL multiple-dose vial. It includes the NDC 42023-115-10, dosage instructions, and the labeler Par Health USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.